HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Loss of intestinal O-glycans promotes spontaneous duodenal tumors.

Abstract
Mucin-type O-glycans, primarily core 1- and core 3-derived O-glycans, are the major mucus barrier components throughout the gastrointestinal tract. Previous reports identified the biological role of O-glycans in the stomach and colon. However, the biological function of O-glycans in the small intestine remains unknown. Using mice lacking intestinal core 1- and core 3-derived O-glycans [intestinal epithelial cell C1galt1(-/-);C3GnT(-/-) or double knockout (DKO)], we found that loss of O-glycans predisposes DKO mice to spontaneous duodenal tumorigenesis by ∼1 yr of age. Tumor incidence did not increase with age; however, tumors advanced in aggressiveness by 20 mo. O-glycan deficiency was associated with reduced luminal mucus in DKO mice before tumor development. Altered intestinal epithelial homeostasis with enhanced baseline crypt proliferation characterizes these phenotypes as assayed by Ki67 staining. In addition, fluorescence in situ hybridization analysis reveals a significantly lower bacterial burden in the duodenum compared with the large intestine. This phenotype is not reduced with antibiotic treatment, implying O-glycosylation defects, rather than bacterial-induced inflammation, which causes spontaneous duodenal tumorigenesis. Moreover, inflammatory responses in DKO duodenal mucosa are mild as assayed with histology, quantitative PCR for inflammation-associated cytokines, and immunostaining for immune cells. Importantly, inducible deletion of intestinal O-glycans in adult mice leads to analogous spontaneous duodenal tumors, although with higher incidence and heightened severity compared with mice with O-glycans constitutive deletion. In conclusion, these studies reveal O-glycans within the small intestine are critical determinants of duodenal cancer risk. Future studies will provide insights into the pathogenesis in the general population and those at risk for this rare but deadly cancer.
AuthorsNan Gao, Kirk Bergstrom, Jianxin Fu, Biao Xie, Weichang Chen, Lijun Xia
JournalAmerican journal of physiology. Gastrointestinal and liver physiology (Am J Physiol Gastrointest Liver Physiol) Vol. 311 Issue 1 Pg. G74-83 (07 01 2016) ISSN: 1522-1547 [Electronic] United States
PMID27229122 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural)
CopyrightCopyright © 2016 the American Physiological Society.
Chemical References
  • C1galt1 protein, mouse
  • Galactosyltransferases
  • N-Acetylglucosaminyltransferases
Topics
  • Adenocarcinoma (genetics, metabolism, pathology)
  • Animals
  • Cell Line
  • Cell Proliferation
  • Cell Transformation, Neoplastic (genetics, metabolism, pathology)
  • Duodenal Neoplasms (genetics, metabolism, pathology)
  • Duodenitis (metabolism, pathology)
  • Duodenum (metabolism, pathology)
  • Galactosyltransferases (deficiency, genetics)
  • Genetic Predisposition to Disease
  • Glycosylation
  • Mice, 129 Strain
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Mucus (metabolism)
  • N-Acetylglucosaminyltransferases (deficiency, genetics)
  • Phenotype

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: